Cargando…
Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumors (GISTs) are common ICC precursor sarcomas, which are considered to be a potential malignant mesenchymal tumor driven by specific KIT or PDGFRA signals in the gastrointestinal tract. The standard treatment for GIST without metastasis is surgical resection. GIST with me...
Autores principales: | Cao, Lei, Zheng, Kunming, Liu, Yanhong, Song, Peng, Wang, Chuntao, Wang, Hongzhi, Wang, Nan, Zhang, Shiwu, Zhao, Yongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136294/ https://www.ncbi.nlm.nih.gov/pubmed/35646090 http://dx.doi.org/10.3389/fgene.2022.878145 |
Ejemplares similares
-
Identification of imatinib-resistant long non-coding RNAs in gastrointestinal stromal tumors
por: Yan, Jingyi, et al.
Publicado: (2019) -
Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors
por: Hu, Xiangchen, et al.
Publicado: (2022) -
Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
por: Huang, Wen-Kuan, et al.
Publicado: (2020) -
Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor
por: Serrano, César, et al.
Publicado: (2019) -
Laparoscopic and Endoscopic Cooperative Dissection for Small Gastric Gastrointestinal Stromal Tumor without Causing Injury to the Mucosa
por: Cao, Lei, et al.
Publicado: (2019)